Salesforce Adds 2 Board Members. It’s Gearing Up for the Agentic AI Era.

Salesforce is seeking to deploy an AI agent solution that integrates with its existing software. (Stephen Lam/Getty Images)

Salesforce added two new faces to its board of directors as the enterprise software company looks to beef up its technical expertise amid a push into agentic artificial intelligence.

Former Cisco and Google executive Amy Chang and former Nvidia engineer David B. Kirk are joining the board effective immediately, the company said in a Wednesday news release.

“Their exceptional experience driving innovation and deep technical expertise will be invaluable as we unlock the full potential of human-AI collaboration and digital labor,” said CEO and Chairman Marc Benioff.

Salesforce stock was down 1.1% at $270.54 early on Wednesday afternoon.

Benioff framed the additions of Chang and Kirk as part of the company’s effort to build and deploy Agentforce, an AI agent solution that integrates with existing Salesforce software. Last month, the company reached an agreement to acquire the cloud data company Informatica in an $8 billion deal with the same goals.

Chang led Cisco’s Collaboration business from 2018 to 2021 after the company acquired her business intelligence startup Accompany, which is now defunct, for $270 million. She now serves on the boards of Walt Disney and Procter & Gamble.

Kirk, meanwhile, is a former chief scientist at Nvidia who has invented nearly 100 patented technologies in computer graphics, hardware, and software, Salesforce said. He is now a partner at the healthcare and AI-focused venture-capital firm DigitalDx Ventures, according to the firm’s website.

With shares are down 19% so far in 2025, Salesforce’s AI play has done little to excite investors in recent months. Some Wall Street analysts expressed concerns about the pricey Informatica deal, saying Salesforce has a mixed record on big acquisitions.

Most analysts remain bullish on the company, however. Among the 58 analysts polled by FactSet, 44 rate the stock at Buy or Overweight.

Write to Nate Wolf at nate.wolf@barrons.com